MA28005A1 - Traitement preoperatoire de la douleur postoperatoire - Google Patents

Traitement preoperatoire de la douleur postoperatoire

Info

Publication number
MA28005A1
MA28005A1 MA28831A MA28831A MA28005A1 MA 28005 A1 MA28005 A1 MA 28005A1 MA 28831 A MA28831 A MA 28831A MA 28831 A MA28831 A MA 28831A MA 28005 A1 MA28005 A1 MA 28005A1
Authority
MA
Morocco
Prior art keywords
postoperative pain
preoperative treatment
surgery
dosage form
patient
Prior art date
Application number
MA28831A
Other languages
English (en)
Inventor
Daniel A Spyker
Bruce E Reidenberg
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of MA28005A1 publication Critical patent/MA28005A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Processing Of Meat And Fish (AREA)

Abstract

On décrit un procédé pour traiter la douleur postopératoire chez un patient subissant une intervention chirurgicale. Le procédé est basé sur une administration préopératoire d'une forme de dosage transdermique contenant de la buprénorphine. La forme de dosage peut être administrée à un patient par exemple 1 à 4 jours avant l'intervention chirurgicale. Des modes de réalisation alternatifs de l'intervention concluent des formes de dosage transdermiques subséquentes pour traiter la douleur postopératoire.
MA28831A 2003-07-25 2006-02-23 Traitement preoperatoire de la douleur postoperatoire MA28005A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25

Publications (1)

Publication Number Publication Date
MA28005A1 true MA28005A1 (fr) 2006-07-03

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28831A MA28005A1 (fr) 2003-07-25 2006-02-23 Traitement preoperatoire de la douleur postoperatoire

Country Status (28)

Country Link
US (3) US20080026042A1 (fr)
EP (1) EP1638492B1 (fr)
JP (1) JP5632573B2 (fr)
KR (4) KR20060054346A (fr)
CN (1) CN1829489B (fr)
AT (1) ATE382354T1 (fr)
AU (1) AU2004261181B2 (fr)
BR (1) BRPI0412924A (fr)
CA (1) CA2529983C (fr)
CY (1) CY1107352T1 (fr)
DE (1) DE602004011055T2 (fr)
DK (1) DK1638492T3 (fr)
EA (1) EA009213B1 (fr)
ES (1) ES2299871T3 (fr)
GE (1) GEP201606538B (fr)
HK (1) HK1087907A1 (fr)
HR (1) HRP20080146T3 (fr)
IL (1) IL173345A (fr)
IS (1) IS8186A (fr)
MA (1) MA28005A1 (fr)
MX (1) MXPA06000990A (fr)
NO (1) NO326636B1 (fr)
NZ (1) NZ594154A (fr)
PL (1) PL1638492T3 (fr)
PT (1) PT1638492E (fr)
UA (1) UA81689C2 (fr)
WO (1) WO2005011578A2 (fr)
ZA (1) ZA200510071B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
JP2011251944A (ja) * 2010-06-02 2011-12-15 Kansai Medical Univ 埋植用鎮痛製剤
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
WO2012031252A1 (fr) * 2010-09-03 2012-03-08 Abbott Laboratories Compositions de buprénorphine à dose élevée et utilisation en tant qu'analgésique
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией
RU2487734C1 (ru) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Способ послеоперационного обезболивания
RU178867U1 (ru) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Вакуумная микроразмерная кристаллизационная ячейка
RU2649961C1 (ru) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела
WO2024055006A2 (fr) * 2022-09-09 2024-03-14 The Regents Of The University Of California Compositions pour prévenir la transition de la douleur aiguë à la douleur chronique

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
EP0484543B1 (fr) * 1990-04-24 1995-12-13 Teijin Limited Emplatre
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (fr) * 1996-04-23 2000-07-11 Jonathan P. Wong Utilisation de ciprofloxacine encapsulee dans un liposome comme medicament immunotherapeutique
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (ko) * 1998-12-17 2003-07-16 주식회사 삼양사 부프레놀핀을함유하는경피투여조성물및이를포함하는패취
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
AU2001262683A1 (en) * 2000-06-02 2001-12-17 Teijin Limited Buprenorphine-containing patch
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
DK1424973T3 (da) * 2001-04-23 2010-06-14 Euro Celtique Sa Bortskaffelsessystem til transdermal doseringsform
ES2377672T3 (es) * 2001-05-01 2012-03-29 Euro-Celtique S.A. Sistemas transdérmicos resistentes al abuso que contienen opioides
JP4302991B2 (ja) * 2001-05-22 2009-07-29 ユーロ−セルティーク エス．エイ． 経皮性剤形を分配する容器及び装置
AU2003297073A1 (en) * 2002-12-13 2004-07-09 Euro-Celtique S.A. Transdermal buprenorphine dosage regimen for analgesia

Also Published As

Publication number Publication date
JP2007500133A (ja) 2007-01-11
KR20120128715A (ko) 2012-11-27
ES2299871T3 (es) 2008-06-01
DE602004011055D1 (de) 2008-02-14
DK1638492T3 (da) 2008-05-13
KR20080011248A (ko) 2008-01-31
UA81689C2 (ru) 2008-01-25
AU2004261181B2 (en) 2009-08-06
KR20060054346A (ko) 2006-05-22
HK1087907A1 (en) 2006-10-27
IL173345A0 (en) 2006-06-11
WO2005011578A3 (fr) 2005-09-09
PT1638492E (pt) 2008-03-17
EP1638492A2 (fr) 2006-03-29
JP5632573B2 (ja) 2014-11-26
AU2004261181A1 (en) 2005-02-10
EA200600284A1 (ru) 2006-06-30
US20080026042A1 (en) 2008-01-31
CN1829489B (zh) 2010-12-15
EP1638492B1 (fr) 2008-01-02
HRP20080146T3 (en) 2008-04-30
CA2529983A1 (fr) 2005-02-10
NZ594154A (en) 2012-12-21
CN1829489A (zh) 2006-09-06
BRPI0412924A (pt) 2006-09-26
WO2005011578A2 (fr) 2005-02-10
MXPA06000990A (es) 2006-04-11
US20140221413A1 (en) 2014-08-07
EP1638492A4 (fr) 2006-07-19
DE602004011055T2 (de) 2008-12-18
NO326636B1 (no) 2009-01-26
CY1107352T1 (el) 2012-12-19
ATE382354T1 (de) 2008-01-15
EA009213B1 (ru) 2007-12-28
KR20090031961A (ko) 2009-03-30
PL1638492T3 (pl) 2008-06-30
ZA200510071B (en) 2006-11-29
IL173345A (en) 2010-06-16
GEP201606538B (en) 2016-09-12
CA2529983C (fr) 2010-07-20
IS8186A (is) 2005-12-19
US20110002975A1 (en) 2011-01-06
NO20060912L (no) 2006-04-21

Similar Documents

Publication Publication Date Title
MA28005A1 (fr) Traitement preoperatoire de la douleur postoperatoire
SG146666A1 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
IS8187A (is) Meðferð á fráhvarfseinkennum
BR0111591A (pt) Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes
DE60320770D1 (de) Verfahren zur verabreichung von buprenorphin zur behandlung von depression
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
WO2004039325A3 (fr) Compositions contenant un inhibiteur de jnk destinees a traiter, prevenir, gerer et/ou modifier la douleur, et leurs methodes d'utilisation
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
ATE310509T1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
RU2423118C1 (ru) Способ лечения трофических язв
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
WO2008088987B1 (fr) Traitement d'une douleur avec de la naloxone
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
Biedermann et al. Acupuncture and myofascial pain: treatment failure after administration of tricyclic antidepressants
DE602004025001D1 (de) Verbindungen zur behandlung von neuropathischen schmerzen und migräne
RU2295986C2 (ru) Способ послеоперационной реабилитации
DE60108775T8 (de) Methode zur behandlung von schlaganfall
ATE403424T1 (de) Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa
RU2006124481A (ru) Способ лечения трофических язв при синдроме "диабетической стопы"